| Original language | English |
|---|---|
| Pages (from-to) | 180-180 |
| Number of pages | 1 |
| Journal | Breast |
| Volume | 62 |
| Early online date | 29 Jan 2022 |
| DOIs | |
| Publication status | Published - 1 Apr 2022 |
Response to: Effect of dose reductions on clinical outcomes, or of outcomes on dose reductions?
R K Ismail*, J van Breeschoten, M W J M Wouters, M van Dartel, S van der Flier, A K L Reyners, P de Graeff, A M G Pasmooij, A de Boer, K E Broekman, D L Hilarius
*Corresponding author for this work
- Dutch Institute for Clinical Auditing
- VU University Medical Center Amsterdam
- Medicines Evaluation Board
- Co€operatie VGZ U.A
- University Medical Center Groningen
- Maastricht University Medical Center+, Department of Clinical Pharmacy and Toxicology, Maastricht, The Netherlands; Radboud University Nijmegen Medical Center, Department of Pharmacy, Nijmegen, The Netherlands. Electronic address: [email protected].
Research output: Contribution to journal › Letter › Academic › peer-review